MaxCyte, Inc.
MXCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $436 | $485 | $555 | $923 |
| - Cash | $28 | $47 | $11 | $48 |
| + Debt | $18 | $19 | $16 | $6 |
| Enterprise Value | $426 | $458 | $560 | $881 |
| Revenue | $39 | $41 | $44 | $34 |
| % Growth | -6.4% | -6.7% | 30.6% | – |
| Gross Profit | $32 | $37 | $39 | $30 |
| % Margin | 81.6% | 88.5% | 88.5% | 89.2% |
| EBITDA | -$46 | -$44 | -$25 | -$17 |
| % Margin | -120.1% | -106.9% | -55.7% | -49% |
| Net Income | -$41 | -$38 | -$24 | -$19 |
| % Margin | -106.3% | -91.8% | -53.3% | -56.3% |
| EPS Diluted | -0.39 | -0.37 | -0.19 | -0.22 |
| % Growth | -5.4% | -94.7% | 13.6% | – |
| Operating Cash Flow | -$28 | -$22 | -$15 | -$11 |
| Capital Expenditures | -$2 | -$4 | -$18 | -$4 |
| Free Cash Flow | -$29 | -$25 | -$33 | -$15 |